Get Started

Medical device innovators honored at 2026 Edison Awards

Medical Design & Outsourcing· June 22, 2026

Leading medical technology developers including Medtronic, Abbott, and Boston Scientific were recognized for excellence in innovation at the 2026 Edison Awards in Fort Myers, Florida. The awards highlight advancements across critical subcategories such as surgical robotics, AI-augmented diagnostics, and women’s health. These accolades underscore the industry's shift toward miniaturization, remote capabilities, and AI integration to improve patient outcomes and clinical efficiency.

The 2026 Edison Awards evaluated over 150 finalists, with winners selected by a panel of global executives and innovation leaders. Major industry players secured top honors for devices that push the boundaries of traditional treatment. Abbott’s Liberta RC DBS system was recognized as the world’s smallest deep brain stimulation device featuring remote programming for movement disorders, while Medtronic’s Altaviva device offered a miniaturized solution for urge urinary incontinence. These developments reflect a broader trend in the medical device sector toward less invasive, highly portable, and long-lasting implantable technologies.

AI and digital health solutions featured prominently among the winners, demonstrating the increasing reliance on software to enhance diagnostic accuracy. Heartflow’s Plaque Analysis and Viz.ai’s Hemorrhage AI were noted for their ability to transform standard imaging into actionable 3D maps and urgent alerts, respectively. In the surgical space, Medical Microinstruments (MMI) and Alcon were highlighted for their robotic and vitreoretinal systems, which aim to improve procedural stability and efficiency. Additionally, HemoSonics’ Quantra system stood out as the first viscoelastic testing platform FDA-cleared specifically for managing postpartum hemorrhage in obstetrics.

The awards also showcased specialized innovations in orthopedics, dentistry, and women’s health. Arthrex received recognition for its Synergy Power System and spine compression screws, while SprintRay’s Midas 3D printer was cited for its rapid production of dental crowns in under 10 minutes. Novel therapies like OhmBody’s wearable nerve stimulator for menstrual symptoms and LigamiX’s bioengineered ligaments illustrate the sector's expansion into non-invasive and regenerative solutions. Collectively, these innovations represent a significant leap forward in human-centered design and precision therapy, setting new benchmarks for the medical device market in 2026.

Read the full story at Medical Design & Outsourcing

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to Medical Design & Outsourcing.

More in Medical Devices

The EU Medical Device Shake-Up: What International Companies Should Prepare For

The European Commission has introduced major proposals to amend the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to address critical implementation challenges and supply chain risks. These reforms aim to streamline regulatory processes and reduce administrative burdens by shifting toward a more proportionate, risk-based system. For the medical device sector, these changes are vital for maintaining market access and ensuring that innovative technologies reach patients without the delays caused by previous regulatory backlogs.

June 21, 2026

CMS and FDA Announce New RAPID Program for Medicare Coverage of Breakthrough Medical Devices

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have introduced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate patient access to innovative medical technologies. This initiative aims to reduce the historical delay between FDA authorization and Medicare national coverage from over a year to as little as two months for qualifying Breakthrough Devices. By aligning regulatory and reimbursement evidence requirements early in the development process, the program seeks to provide a more predictable commercialization path for manufacturers of Class II and Class III devices.

June 21, 2026

The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units

A recent analysis published in Nature examines the current regulatory and market landscape for artificial intelligence-enabled medical devices within intensive care units in the European Union and the United States. The study highlights the growing integration of AI technologies into critical care environments, focusing on how these devices are categorized and approved for clinical use. This overview is significant for the medical device sector as it underscores the technical and regulatory hurdles facing developers of high-stakes diagnostic and monitoring software.

June 21, 2026

MedTech Breakthrough Awards recognize top medical device, medtech innovations

The MedTech Breakthrough Awards have announced their latest recognition of leading innovations within the medical device and healthcare technology sectors. This annual awards program highlights excellence across various categories, including robotics, telehealth, and clinical administration. For the medical device industry, these accolades serve as a benchmark for technological advancement and market leadership among both established firms and emerging startups.

June 21, 2026